论文部分内容阅读
达美康作为口服第2代磺豚类降糖药在国内外临床应用已10余年。由于其生理半衰期长，同时可减低血小板粘附力，因而一直被认为是老年NIDDM（非胰岛素依赖型糖尿病）患者有效而安全的药物。199o年以来笔者发现5例服用达美康后出现低血糖症的病例，报告如下。临床资料男4例，女1例
As a oral second generation of Sulphurous Dolphin hypoglycemic agents in clinical application at home and abroad for more than 10 years. Because of its long physiological half-life and reduced platelet adhesion, it has long been considered an effective and safe drug for elderly patients with NIDDM (non-insulin-dependent diabetes mellitus). 199o years I found five cases of taking hypmelliates after damason cases, the report is as follows. Clinical data of 4 males and 1 female